1,2-distearoylphosphatidylethanolamine has been researched along with Atherogenesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Catelani, T; Cervadoro, A; Decuzzi, P; Di Francesco, V; Ferreira, MFMM; Gurgone, D; Maffia, P; Palomba, R | 1 |
| Dong, Y; Duan, Y; Fu, H; Li, D; Li, Z; Luo, X; Shen, M; Sun, Y; Wang, L; Wu, Z; Xu, C | 1 |
| Ait-Arsa, I; Benard, S; Couprie, J; Dioury, F; Ferroud, C; Gimié, F; Giraud, P; Guibbal, F; Idoumbin, JP; Jestin, E; Khantalin, I; Meilhac, O; Meneyrol, V; Patché, J; Yong-Sang, J | 1 |
3 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Atherogenesis
| Article | Year |
|---|---|
Modulating Lipoprotein Transcellular Transport and Atherosclerotic Plaque Formation in ApoE
Topics: Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis; ATP Binding Cassette Transporter 1; Diet, High-Fat; Interleukin-1beta; Lipoproteins, LDL; Liposomes; Macrophages; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Nanomedicine; Nanoparticles; Particle Size; Phosphatidylethanolamines; RAW 264.7 Cells | 2020 |
Efficient Treatment of Atherosclerosis by Dexamethasone Acetate and Rapamycin Co-Loaded mPEG-DSPE Calcium Phosphate Nanoparticles.
Topics: Animals; Atherosclerosis; Autophagy; Calcium Phosphates; Dexamethasone; Endothelial Cells; Lipoproteins, LDL; Mice; Nanoparticles; Phosphatidylethanolamines; Sirolimus | 2020 |
Development, synthesis, and
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Chelating Agents; Drug Carriers; Drug Development; Gallium Radioisotopes; Heterocyclic Compounds, 2-Ring; Humans; Lipoproteins, HDL; Liver; Mice, Knockout; Myocardium; Phosphatidylethanolamines; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |